Dr. Joshua Schrecker is a member of the clinical team at Aegis Sciences Corporation. He received his Doctor of Pharmacy from the University of Tennessee College of Pharmacy. He has expertise in developing leadership skills within a corporate environment and has received certifications through completion of advanced cardiac life support courses. On this episode, Dr. Schrecker discusses the clinical utility and role of urine drug screens. 

Dysautonomia is the most important nervous system problem you have probably never heard about. It is a vast grouping of diseases that affects the body's most basic functions that occurs below the level of direct conscious control--temperature control, digestion, and regulation of blood pressure are some of the critical functions of this unheralded system. When things go wrong with the system, it is obvious to patients. The problem is the cultural awareness and conventional medical system has been slow to recognize and effectively treat this dysautonomia.

Enter: Kelly Freeman. A survivor turned patient advocate, Kelly is the founder of The Dysautonomia Project dedicated to educating patients and clinical providers alike to close this big gap. Having survived dysautonomia herself, she has founded The Dysautonomia Project to provide patient advocacy and education. She is the co-author of a book of the same name and her website can be found at thedysautonomiaproject.org.

Dr. Christina Hayhurst is an assistant professor of Anesthesiology and Critical Care medicine at Vanderbilt University Medical Center. She trained at the University of Virginia, where she first began to explore opioid-sparing anesthetics and the effects of high-dose opioids on post-operative outcomes. At Vanderbilt, in addition to critical care, she is a member of the Perioperative Anesthesia service, which designs and implements enhanced recovery protocols for a variety of surgical services, with an emphasis on opioid reduction. Her research interests include the clinical implications of opioid-induced hyperalgesia in the perioperative and critically ill patient populations.